The Biomerica COVID-19 IgG test is an in vitro Enzyme-Linked Immunosorbent Assay (ELISA) for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum and plasma (K2 EDTA) specimens. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, to perform high complexity tests.
This Test Has Not Been Reviewed by the FDA
For Prescription Use Only
For In Vitro Diagnostic Use Only